University of Texas at Austin at SLAS2027
Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website
University of Texas at Austin brings 1 presentation to SLAS2027 in San Diego. Its program is the podium session on hybrid therapeutic modalities such as antibody-drug conjugates and siRNA, in the New Modalities track.
| Organization | SLAS2027 Attendance |
|---|---|
University of Texas at Austin Austin, TX | |
Public research university in Austin, Texas. | Session Tue Feb 2 3–5pm Driving Innovation in Hybrid Therapeutic Modalities (i.e., ADC, siRNA)
Also |
Instantly find 20 buyers from University of Texas at Austin
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction